Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Market Cap	46.26B
Revenue (ttm)	13.74B
Net Income (ttm)	1.68B
Shares Out	91.67M
EPS (ttm)	18.29
PE Ratio	27.59
Forward PE	24.90
Dividend	4.50 (0.95%)
Ex-Dividend Date	Sep 18, 2025

Volume	1,047,842
Average Volume	201,671
Open	475.60
Previous Close	471.85
Day's Range	473.00 - 510.50
52-Week Range	307.25 - 572.00
Beta	0.61
RSI	65.22
Earnings Date	Nov 3, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric s...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,035
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDRAMEDCO

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.